Soulbrain Overview
- Year Founded
-
1986
- Status
-
Public
- Employees
-
1,175
- Stock Symbol
-
357780
- Investments
-
21
- Share Price
-
$179.02
- (As of Friday Closing)
Soulbrain General Information
Description
Soulbrain Co Ltd is engaged in the business of supplying chemical materials and battery materials for manufacturing semi-conductor materials, display materials, and secondary batteries. Also, the company is engaged in producing various electronic materials required for the process of LED, solar power generation, and electric vehicles. It plans to enter the bio-healthcare business in future.
Contact Information
Website
www.soulbrain.co.krCorporate Office
- 52, Geumto-ro, Sujeong-gu
- Seongnam, Gyeonggi 13486
- South Korea
Corporate Office
- 52, Geumto-ro, Sujeong-gu
- Seongnam, Gyeonggi 13486
- South Korea
Soulbrain Stock Performance
As of 20-Nov-2026, Soulbrain’s stock price is $179.02. Its current market cap is $1.36B with 7.62M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $179.02 | $196.64 | $148.09 - $370.41 | $1.36B | 7.62M | 32.2K | $11.49 |
Soulbrain Financials Summary
As of 30-Jun-2026, Soulbrain has a trailing 12-month revenue of $731M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,678,101 | 1,287,345 | 677,034 | 1,621,533 |
| Revenue | 730,996 | 648,836 | 632,756 | 645,554 |
| EBITDA | 169,570 | 123,185 | 158,552 | 162,321 |
| Net Income | 87,955 | 55,552 | 86,803 | 99,708 |
| Total Assets | 1,036,889 | 1,004,681 | 793,101 | 772,452 |
| Total Debt | 20,528 | 81,431 | 1,560 | 1,308 |
Soulbrain Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Soulbrain Patents
Soulbrain Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4826117-A2 | Method of manufacturing thin film and apparatus for manufacturing thin film | Pending | 17-Apr-2025 | ||
| EP-4826117-A3 | Method of manufacturing thin film and apparatus for manufacturing thin film | Pending | 17-Apr-2025 | ||
| EP-4826118-A1 | Azeotropic mixture, method of depositing thin film, and semiconductor substrate and semiconductor device fabricated therefrom | Pending | 15-Apr-2025 | ||
| US-20260337775-A1 | Azeotropic mixture, method of depositing thin film, and semiconductor substrate and semiconductor device fabricated therefrom | Pending | 15-Apr-2025 | ||
| US-20260314286-A1 | Composition for wet etching and manufacturing method of semiconductor device using the composition | Pending | 08-Apr-2025 | H10P50/683 |
Soulbrain Signals
Soulbrain Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Soulbrain Investments & Acquisitions (21)
Soulbrain’s most recent deal was a Buyout/LBO with ARK Diagnostics for . The deal was made on 28-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ARK Diagnostics | 28-Oct-2025 | Buyout/LBO | Diagnostic Equipment | ||
| Bilix | 30-Sep-2025 | Later Stage VC | Drug Discovery | ||
| AIBIT | 01-Sep-2025 | Merger/Acquisition | Electrical Equipment | ||
| Genechem (Biotechnology) | 02-Jan-2025 | Secondary Transaction - Private | Biotechnology | ||
| Genic (Seongnam) | 15-Jul-2024 | PIPE | Personal Products |
Soulbrain ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
18.48 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Chemicals
Industry
of 503
Rank
Percentile
Commodity Chemicals
Subindustry
of 208
Rank
Percentile
Soulbrain Exits (1)
Soulbrain’s most recent exit was on 01-Jan-2009 from Phicom. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Phicom | 01-Jan-2009 | Completed |
|
Soulbrain Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| PixCell Medical Technologies | Yokneam Ilit, Israel | 2008 | |
| Genechem (Biotechnology) | Daejeon, South Korea | 1997 |
Soulbrain FAQs
-
When was Soulbrain founded?
Soulbrain was founded in 1986.
-
Where is Soulbrain headquartered?
Soulbrain is headquartered in Seongnam, South Korea.
-
What is the size of Soulbrain?
Soulbrain has 1,175 total employees.
-
What industry is Soulbrain in?
Soulbrain’s primary industry is Industrial Chemicals.
-
Is Soulbrain a private or public company?
Soulbrain is a Public company.
-
What is Soulbrain’s stock symbol?
The ticker symbol for Soulbrain is 357780.
-
What is the current stock price of Soulbrain?
As of 20-Nov-2026 the stock price of Soulbrain is $179.02.
-
What is the current market cap of Soulbrain?
The current market capitalization of Soulbrain is $1.36B.
-
What is Soulbrain’s current revenue?
The trailing twelve month revenue for Soulbrain is $731M.
-
What is Soulbrain’s annual earnings per share (EPS)?
Soulbrain’s EPS for 12 months was $11.49.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process